Life Science

Global Antisense & RNAi Therapeutics Market Research: Key Companies Profile with Sales, Revenue, Price and Competitive Situation Analysis

Antisense therapy is a form of treatment for genetic disorders or infections. When the genetic sequence of a particular gene is known to be causative of a particular disease, it is possible to synthesize a strand of nucleic acid (DNA, RNA or a chemical analogue) that will bind to the messenger RNA (mRNA) produced by that gene and inactivate it, effectively turning that gene “off”.

Market share of global Antisense & RNAi Therapeutics industry is dominate by companies like Glaxo Smith Kline, Sanofi Aventis / Genzyme, Isis Pharmaceuticals/ Ionis Pharmaceuticals, Arbutus Biopharma Ltd., Silence Therapeutics, Bio-Path Holdings Inc., Calando Pharmaceuticals, ICo Therapeutics, Quark Pharmaceuticals, Rexhan Pharmaceuticals, Biomarin/Prosensa, Regulus Therapeutics, Rxi Pharmaceuticals, Silenseed, Dicerna Pharmaceuticals, Sirnaomics Inc. and others which are profiled in this report as well in terms of Sales, Price, Revenue, Gross Margin and Market Share (2017-2018).

Access Report Details at:

With the help of 15 chapters spread over 100 pages this report describe Antisense & RNAi Therapeutics Introduction, product scope, market overview, market opportunities, market risk, and market driving force. Later it provide top manufacturers sales, revenue, and price of Antisense & RNAi Therapeutics, in 2017 and 2018 followed by regional and country wise analysis of sales, revenue and market share. Added to above, the important forecasting information by regions, type and application, with sales and revenue from 2019 to 2024 is provided in this research report. At last information about Antisense & RNAi Therapeutics sales channel, distributors, traders, dealers, and research findings completes the global Antisense & RNAi Therapeutics market research report.

Market Segment by Regions, regional analysis covers:

  • North America (USA, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Columbia, etc.)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers:

  • RNA interference
  • SiRNA
  • MiRNA
  • Antisense RNA

Market Segment by Applications, can be divided into

  • Oncology
  • Cardiovascular
  • Renal
  • Neurodegenerative
  • Respiratory
  • Genetic
  • Infectious Diseases

Purchase this premium research report at:

Table of Contents

1 Market Overview

2 Manufacturers Profiles

3 Global Antisense & RNAi Therapeutics Market Competitions, by Manufacturer

4 Global Antisense & RNAi Therapeutics Market Analysis by Regions

5 North America Antisense & RNAi Therapeutics by Countries

6 Europe Antisense & RNAi Therapeutics by Countries

7 Asia-Pacific Antisense & RNAi Therapeutics by Countries

8 South America Antisense & RNAi Therapeutics by Countries

9 Middle East and Africa Antisense & RNAi Therapeutics by Countries

10 Global Antisense & RNAi Therapeutics Market Segment by Type

11 Global Antisense & RNAi Therapeutics Market Segment by Application

12 Antisense & RNAi Therapeutics Market Forecast (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

Ask your report related queries at: